Monitor this situation.
Unsubscribe anytime.
[SITUATION] · [QUIET] · [BUSINESS]
2 clusters · 6 sources · 2 days · First seen · Last updated
Corporate quarterly earnings reports
Overview
The period saw financial reporting from major corporations. Elanco Animal Health reported third-quarter revenue of US$ 1.3 billion, an 11 percent increase from the previous year, moving from a net loss in 2025 to a net profit of US$ 18.0 million. Growth was driven by the Pet Health and livestock segments.
Alcon reported third-quarter revenue of $2.72 billion, a 5 percent increase in constant currency. The company saw growth in its Vision Care and Surgical segments, though it noted competitive pressure regarding intraocular lenses in the United States.
Entities
AHV International · European Medicines Agency · Alcon · David Endicott · Jeff Simmons
Timeline
-
[BUSINESS] 4 sourcesAlcon reports third quarter revenue growth to $2.7 billion
Alcon reported a 5 percent revenue increase to $2.72 billion in Q3, driven by Vision Care despite competitive pressure on intraocular lenses in the US.
-
[BUSINESS] 2 sourcesElanco reports US$ 1.3 billion in third quarter revenue
Elanco Animal Health reported US$ 1.3 billion in Q3 2026 revenue, an 11% increase, and raised its full-year financial guidance.
Sources
ad-hoc-news.de · cash.ch · finanzen.ch · forbes.com.br · optimoda.es · vgnews.com.br